Diagnostics
Ageing populations in the developed nations, an increasingly comprehensive and accessible healthcare system in emerging countries such as India and China, new technologies, and increasing awareness about infectious diseases like hepatitis and HIV are the main growth drivers for global diagnostics, a market with huge business opportunities.
Do you want to be a leading player in one of the fastest growing healthcare sectors? Make informed business decisions with the reliable data and
forecasts provided by the publications listed under Research and Markets’ Diagnostics category.
Our reports, books, and subscriptions cover every conceivable aspect of this dynamic and multifarious sector of medicine. To help you find quickly the information resource that answers to your key market questions, the extensive coverage of this category has been divided into 13 sub-categories covering a specific segment: Home Testing, In Vitro Diagnostics, Glucose Testing, Point-of-Care Diagnostics, Diagnostic Imaging, Drug Abuse Screening, Rapid Coagulation Testing, Rapid Cardiac Markers, Infectious Disease Testing, Cholesterol Testing, In-Office Testing, Laboratory Testing Managed Care.
Show Less
Read more
2013 Analysis of the Salmonella Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
The report presents a detailed analysis of the Salmonella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Salmonella definition,...
April
2013
FROM
EUR 3,327USD 4,350GBP 2,804AUD 4,629JPY 426,019SEK 28 804CHF 4'093CAD 4,523
2013 Analysis of the H. Pylori Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
The report presents a detailed analysis of the Helicobacter Pylori diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the H. Pylori definition,...
April
2013
FROM
EUR 3,327USD 4,350GBP 2,804AUD 4,629JPY 426,019SEK 28 804CHF 4'093CAD 4,523
2013 Analysis of the Legionella Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
The report presents a detailed analysis of the Legionella diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Legionella definition,...
April
2013
FROM
EUR 3,327USD 4,350GBP 2,804AUD 4,629JPY 426,019SEK 28 804CHF 4'093CAD 4,523
2013 Analysis of the Streptococci Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
The report presents a detailed analysis of the Streptococci diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Streptococci definition,...
April
2013
FROM
EUR 3,327USD 4,350GBP 2,804AUD 4,629JPY 426,019SEK 28 804CHF 4'093CAD 4,523
2013 Analysis of the Toxoplasmosis Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
The report presents a detailed analysis of the Toxoplasmosis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Toxoplasmosis definition,...
April
2013
FROM
EUR 3,327USD 4,350GBP 2,804AUD 4,629JPY 426,019SEK 28 804CHF 4'093CAD 4,523
2013 Analysis of the Factor Assay Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape
The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific...
April
2013
FROM
EUR 4,092USD 5,350GBP 3,449AUD 5,693JPY 523,954SEK 35 426CHF 5'034CAD 5,563
2013 Analysis of the PT Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape
The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific...
April
2013
FROM
EUR 3,327USD 4,350GBP 2,804AUD 4,629JPY 426,019SEK 28 804CHF 4'093CAD 4,523
2013 Analysis of the AFP Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the...
April
2013
FROM
EUR 3,327USD 4,350GBP 2,804AUD 4,629JPY 426,019SEK 28 804CHF 4'093CAD 4,523
2013 Analysis of the D-Dimer Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape
The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific...
April
2013
FROM
EUR 3,327USD 4,350GBP 2,804AUD 4,629JPY 426,019SEK 28 804CHF 4'093CAD 4,523
2013 Analysis of the Cyclospora Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape
The report presents a detailed analysis of the Cyclospora diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Cyclospora definition,...
April
2013
FROM
EUR 3,327USD 4,350GBP 2,804AUD 4,629JPY 426,019SEK 28 804CHF 4'093CAD 4,523
2013 Analysis of the Herpes Markers Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
The report presents a detailed analysis of the Herpes diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Herpes definition, epidemiology...
April
2013
FROM
EUR 4,169USD 5,450GBP 3,513AUD 5,799JPY 533,748SEK 36 088CHF 5'128CAD 5,667
2013 Analysis of the Chancroid Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
The report presents a detailed analysis of the Chancroid diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chancroid definition, epidemiology...
April
2013
FROM
EUR 3,327USD 4,350GBP 2,804AUD 4,629JPY 426,019SEK 28 804CHF 4'093CAD 4,523
2013 Analysis of the E. Coli Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape
The report contains 200 pages, 7 tables and presents a detailed analysis of the E. Coli diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views...
April
2013
FROM
EUR 3,327USD 4,350GBP 2,804AUD 4,629JPY 426,019SEK 28 804CHF 4'093CAD 4,523
2013 Analysis of the Shigella Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
The report presents a detailed analysis of the Shigella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Shigella definition, epidemiology...
April
2013
FROM
EUR 3,327USD 4,350GBP 2,804AUD 4,629JPY 426,019SEK 28 804CHF 4'093CAD 4,523
2013 Analysis of the Yersinia Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape
The report presents a detailed analysis of the Yersinia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Yersinia definition, epidemiology...
April
2013
FROM
EUR 3,327USD 4,350GBP 2,804AUD 4,629JPY 426,019SEK 28 804CHF 4'093CAD 4,523
2013 Analysis of the Heparin Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape
The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific...
April
2013
FROM
EUR 3,327USD 4,350GBP 2,804AUD 4,629JPY 426,019SEK 28 804CHF 4'093CAD 4,523
2013 Analysis of the PSA Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the...
April
2013
FROM
EUR 3,327USD 4,350GBP 2,804AUD 4,629JPY 426,019SEK 28 804CHF 4'093CAD 4,523
2013 Analysis of the Occult Blood Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the...
April
2013
FROM
EUR 3,327USD 4,350GBP 2,804AUD 4,629JPY 426,019SEK 28 804CHF 4'093CAD 4,523
2013 Analysis of the Enterovirus Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
The report presents a detailed analysis of the Enterovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Enterovirus definition,...
April
2013
FROM
EUR 3,327USD 4,350GBP 2,804AUD 4,629JPY 426,019SEK 28 804CHF 4'093CAD 4,523
2013 Analysis of the Pap Smear/HPV Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--
Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the...
April
2013
FROM
EUR 3,327USD 4,350GBP 2,804AUD 4,629JPY 426,019SEK 28 804CHF 4'093CAD 4,523
